Sorensen to head Siemens Healthcare in U.S., Canada

Source: Siemens Healthcare
Siemens Healthcare has appointed neurologist Gregory Sorensen, MD, as CEO of Siemens Healthcare in the U.S., effective June 1. Sorensen succeeds Randy Hill, who has served as interim CEO. Sorensen also will oversee the Canadian activities of Siemens Healthcare.

Sorensen will be responsible for leading the marketing, sales, service and support functions for Siemens Healthcare in the U.S. and Canada, across the entire healthcare portfolio including medical imaging, therapy, health IT and laboratory diagnostics. He will be based at Siemens Healthcare's U.S. headquarters in Malvern, Pa.

Sorensen is currently serving as professor of radiology and health sciences & technology at Harvard Medical School; is a faculty member of the Harvard-Massachusetts Institute of Technology division of health sciences and technology; and co-director of the A.A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital in Boston.

He is a practicing neuroradiologist whose research has focused on novel oncology agents, such as gene therapy.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.